CARPINIELLO, BERNARDO
 Distribuzione geografica
Continente #
EU - Europa 252.424
NA - Nord America 20.329
AS - Asia 2.971
AF - Africa 44
OC - Oceania 40
SA - Sud America 34
Continente sconosciuto - Info sul continente non disponibili 13
Totale 275.855
Nazione #
IT - Italia 242.943
US - Stati Uniti d'America 20.061
UA - Ucraina 3.983
CN - Cina 2.432
SE - Svezia 1.999
FI - Finlandia 934
DE - Germania 888
GB - Regno Unito 797
FR - Francia 436
CA - Canada 255
SG - Singapore 178
VN - Vietnam 116
RU - Federazione Russa 106
IN - India 103
NL - Olanda 62
CH - Svizzera 37
BE - Belgio 35
TR - Turchia 33
IE - Irlanda 32
AU - Australia 30
IR - Iran 24
ES - Italia 23
BR - Brasile 21
RO - Romania 20
JP - Giappone 19
AT - Austria 16
EU - Europa 13
CZ - Repubblica Ceca 12
MX - Messico 12
HK - Hong Kong 11
MU - Mauritius 10
NZ - Nuova Zelanda 10
BG - Bulgaria 9
GR - Grecia 9
HR - Croazia 9
HU - Ungheria 9
PL - Polonia 9
PT - Portogallo 9
GH - Ghana 7
KR - Corea 7
PH - Filippine 7
SA - Arabia Saudita 7
DK - Danimarca 6
EG - Egitto 6
IL - Israele 6
ZA - Sudafrica 6
EE - Estonia 5
LU - Lussemburgo 5
MM - Myanmar 5
MY - Malesia 5
NG - Nigeria 5
NO - Norvegia 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
IS - Islanda 4
PE - Perù 4
CL - Cile 3
CM - Camerun 3
CO - Colombia 3
EC - Ecuador 3
LV - Lettonia 3
PK - Pakistan 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
ID - Indonesia 2
LB - Libano 2
MW - Malawi 2
SI - Slovenia 2
TH - Thailandia 2
TZ - Tanzania 2
AM - Armenia 1
CR - Costa Rica 1
ET - Etiopia 1
LI - Liechtenstein 1
MC - Monaco 1
MD - Moldavia 1
MT - Malta 1
SM - San Marino 1
TN - Tunisia 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 275.855
Città #
Cagliari 238.124
Chandler 2.618
Jacksonville 2.134
Fairfield 1.865
Woodbridge 1.577
Ann Arbor 1.261
Wilmington 1.044
Ashburn 1.015
Houston 985
Nyköping 968
Boardman 839
Seattle 677
Boston 650
Nanjing 634
Cambridge 573
Milan 396
Helsinki 360
Rome 309
Dearborn 250
Beijing 242
Toronto 207
Shenyang 202
Nanchang 170
Changsha 155
San Diego 151
Verona 149
Hebei 147
Shanghai 135
Jiaxing 130
Redwood City 124
New York 120
Tianjin 115
Dong Ket 114
Norwalk 113
Orange 102
Jinan 80
Guangzhou 79
Zhengzhou 69
Washington 68
Ningbo 63
Saint Petersburg 54
Bologna 52
Chicago 51
Florence 51
London 49
Sassari 49
Pune 44
Turin 44
Mountain View 41
Redmond 41
Torino 38
Borås 35
Padova 35
Hangzhou 34
Millbury 34
Brussels 31
Taizhou 31
Bari 30
Amsterdam 28
Naples 28
Napoli 27
San Mateo 27
Atlanta 26
Parma 26
Phoenix 26
Genoa 25
Brescia 21
Catania 21
Hefei 21
Los Angeles 21
Dallas 20
Pescara 20
Cedar Knolls 18
Dublin 18
Walnut 18
Buffalo 17
Leawood 17
Dalmine 16
Kunming 16
Palermo 16
Falls Church 15
Mumbai 15
Edinburgh 14
Trieste 14
Augusta 13
Perugia 13
Vienna 13
Istanbul 12
Kilburn 12
Monteprandone 12
Taranto 12
Vicenza 12
Catanzaro 11
Frankfurt am Main 11
Livorno 11
Meda 11
Messina 11
Novara 11
Oristano 11
São Paulo 11
Totale 260.476
Nome #
Psychopathology, psychosocial factors and obesity 3.397
The asthma-anxiety connection 3.082
Validation of the italian version of the compensatory eating and behaviors in response to alcohol consumption scale (CEBRACS) 2.944
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 2.845
Assessment of eating disorders with the diabetes eating problems survey - revised (DEPS-R) in a representative sample of insulin-treated diabetic patients: a validation study in Italy 2.785
Obesity, alexithymia and psychopathology: A case-control study 2.769
Mental disorders in patients with metabolic syndrome. The key role of central obesity 2.709
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 2.593
Mental disorders in obese patients with and without metabolic syndrome 2.576
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study 2.539
Clinical global impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders 2.388
Exploring the role of gut microbiota in major depressive disorder and in treatment resistance to antidepressants 2.380
Obesità e psicopatologia 2.327
Obesità e psicopatologia 2.318
Obesità, sindrome metabolica e comorbidità psichiatriche 2.260
BDNF serum levels as a biomarker of depressive symptoms in psychotic disorders 2.240
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.179
Obesità, sindrome metabolica e comorbidità psichiatriche 2.146
The longitudinal trajectory of serum brain-derived neurotrophic factor (BDNF) levels in psychotic patients: a prospective observational study 2.106
Disturbi da uso di sostanze e malattie dentali: lo stato dell’arte 1.999
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 1.987
Obesità e qualità della vita 1.928
Challenges and Future Prospects of Precision Medicine in Psychiatry 1.869
Obesità e alessitimia 1.758
Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease 1.755
Psychiatric comorbidity and quality of life in obese patients. Results from a case-control study 1.737
Obesity and psychopathology. A study of psychiatric comorbidity among patients attending a specialist obesity unit 1.711
Obesità, sindrome metabolica e comorbidità psichiatriche 1.702
Unblending borderline personality and bipolar disorders 1.675
Clinical, genetic, and brain imaging predictors of risk for bipolar disorder in high-risk individuals 1.656
Does duration of untreated psychosis predict very long term outcome of schizophrenic disorders? Results of a retrospective study 1.641
Violence and mental disorders. A retrospective study of people in charge of a community mental health center 1.639
Il modello alternativo del DSM-5 per i disturbi di personalità 1.634
Obesità e alessitimia 1.619
Biomarkers in aggression 1.602
Obesità e comorbidità psichiatrica di Asse I: risultati di uno studio caso – controllo 1.588
Obesità e punteggi all’SCL-90-R 1.585
Asthma and psychiatric disorders 1.583
Mortality in mental disorders: Are we approaching to close the gap respect to other medical specialties? The case of schizophrenia 1.499
The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study 1.479
Diagnostic reliability in schizoaffective disorder 1.479
Peripheral Biomarkers in Schizophrenia: A Meta-Analysis of Microarray Gene Expression Datasets 1.456
Role of palmitoylethanolamide (PEA) in depression: Translational evidence Special Section on “Translational and Neuroscience Studies in Affective Disorders”. Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders 1.456
The complex relationship between self-reported ‘personal recovery’ and clinical recovery in schizophrenia 1.434
Obesità, alessitimia e rappresentazione corporea: risultati di uno studio caso – controllo 1.423
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 1.413
Obesità e comorbidità psichiatrica di asse I: studio caso - controllo 1.396
Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia: a network analysis 1.360
Impulsivity and aggressiveness in bipolar disorder with co-morbid borderline personality disorder 1.347
Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses 1.329
Anatomical distribution and expression of CYP in humans: Neuropharmacological implications 1.304
The Impact of Alexithymia on Treatment Response in Psychiatric Disorders: A Systematic Review 1.284
Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives 1.282
Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the “real-life” 1.221
Clinical correlates of age at onset distribution in bipolar disorder: a comparison between diagnostic subgroups 1.216
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 1.212
The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia 1.210
Duration of untreated illness as a key to early intervention in schizophrenia: A review 1.208
The Italian version of the borderline personality disorder severity index IV: Psychometric properties, clinical usefulness, and possible diagnostic implications 1.195
null 1.170
Personalized psychiatry: Promises and pitfalls 1.159
Critical appraisal of 3-monthly paliperidone depot injections in the treatment of schizophrenia 1.154
Obesità e ansia 1.141
Editorial: Decreasing the Impact of Treatment Resistance in Schizophrenia: Identifying Novel Molecular Targets/Pathways to Increase Treatment Efficacy 1.129
Clinicians' adherence to clinical practice guidelines for cardiac function monitoring during antipsychotic treatment: A retrospective report on 434 patients with severe mental illness 1.128
Obesità e disturbi d’ansia 1.118
Le cure 1.095
Real-world effectiveness of long acting aripiprazole: Treatment persistence and its correlates in the Italian clinical practice 1.091
The reciprocal relationship between suicidality and stigma 1.090
Approccio al trattamento dell’obesità: 5 anni di esperienza in un team multidisciplinare metabolico - psicoeducazionale – motorio 1.087
Accuracy of self-assessment of real-life functioning in schizophrenia 1.087
Disturbo da sintomi somatici e disturbi correlati 1.078
The link between thyroid autoimmunity (antithyroid peroxidase autoantibodies) with anxiety and mood disorders in the community: a field of interest for public health in the future 1.058
Obesità e disturbi di personalità 1.052
Obesità e disturbi di personalità: risultati di uno studio caso - controllo 1.042
Obesità e qualità della vita 1.040
Pattern of gene expression in different stages of schizophrenia: Down-regulation of NPTX2 gene revealed by a meta-analysis of microarray datasets 1.024
Admixture analysis of age at symptom onset and age at disorder onset in a large sample of patients with obsessive-compulsive disorder 1.013
Il disturbo bipolare e la comorbidità con i disturbi di personalità 1.007
null 1.004
Assessment of functioning in patients with schizophrenia and schizoaffective disorder with the Mini-ICF-APP: a validation study in Italy 1.003
Obesità e disturbi di personalità 1.000
Clinical correlates of age at onset distribution in bipolar disorder: a comparison between diagnostic subgroups 1.000
Big data in severe mental illness: the role of electronic monitoring tools and metabolomics 974
Intramuscular long-acting paliperidone palmitate in acute patients with schizophrenia unsuccessfully treated with oral antipsychotics 970
Prevalence and clinical correlates of cognitive symptoms in depression: A naturalistic study 970
Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma 969
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 954
Il femminicidio: un’emergenza psicosociale 948
Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive-compulsive disorder? 939
Treating Depression: What Patients Want; Findings From a Randomized Controlled Trial in Primary Care 921
Schizofrenia e disturbo schizoaffettivo: differenze cliniche, di decorso, esito e trattamento 905
Disturbi dello spettro schizofrenico e comorbidità con i disturbi di personalità 901
Haloperidol and loss of gray matter in schizophrenia: Reconciling meta-analytical results with molecular pharmacology 893
Differenze di genere nella remissione e recovery di pazienti schizofrenici e schizoaffettivi: risultati di uno studio di coorte prospettico 889
I nuovi disturbi del comportamento alimentare 882
Disturbi della nutrizione e dell'alimentazione 875
Behavioural addictions and the transition from DSM-IV-TR to DSM-5 874
Chemokines and pro-inflammatory cytokines in Down's syndrome: An early marker for Alzheimer-type dementia? 865
Osservazioni psichiatrico-forensi sulle imputazioni e condanne agli psichiatri per il comportamento violento del paziente = Charges and convictions of psychiatrists for the violent behavior of the patient: psychiatric-forensic remarks 843
Totale 150.796
Categoria #
all - tutte 393.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 393.543


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.136 0 0 0 0 0 0 0 0 0 0 888 1.248
2019/202049.706 4.498 1.633 308 1.283 16.610 10.862 6.708 1.901 1.262 1.142 1.566 1.933
2020/202178.836 3.161 2.525 3.654 18.949 14.678 9.390 7.434 5.169 2.062 4.690 4.469 2.655
2021/202220.439 2.074 1.744 1.090 1.523 1.842 1.450 973 905 1.419 1.601 2.815 3.003
2022/202333.572 2.930 2.861 2.976 2.633 2.668 3.455 1.398 6.784 2.295 1.687 2.352 1.533
2023/202437.905 2.576 1.506 2.649 4.159 3.965 7.665 6.479 3.071 2.221 3.354 260 0
Totale 276.974